🇺🇸 FDA
Patent

US 10894808

Polypeptide ligands specific for plasma kallikrein

granted A61KA61K38/00A61P

Quick answer

US patent 10894808 (Polypeptide ligands specific for plasma kallikrein) held by BicycleRD Limited expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P29/00